The Diverse Clinical Manifestations of Tuberous Sclerosis Complex: A Review

Seminars in Pediatric Neurology

Volumn 13, Issue 1, 2006, Pages 27-36

  Rosser, Tena ^a   Panigrahy, Ashok ^a   McClintock, William ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

angiomyolipoma; autism; cardiac rhabdomyoma; epilepsy; infantile spasms; subependymal giant cell astrocytoma; tuberous sclerosis

Indexed keywords

ANTICONVULSIVE AGENT; ANTIESTROGEN; GONADORELIN AGONIST; IMMUNOSUPPRESSIVE AGENT; PROGESTERONE; RAPAMYCIN; TAMOXIFEN; VIGABATRIN;

ANGIOMYOLIPOMA; ARTICLE; ASTROCYTOMA; AUTISM; AUTOSOMAL DOMINANT DISORDER; BEHAVIOR DISORDER; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; COGNITIVE DEFECT; DISEASE SEVERITY; EPILEPSY; EYE; GENOTYPE PHENOTYPE CORRELATION; HAMARTOMA; HEART; HUMAN; INFANTILE SPASM; KIDNEY; LUNG; LYMPHANGIOMYOMA; NEPHROTOXICITY; PATIENT CARE; PHAKOMATOSIS; RADIOGRAPHY; RETINA DISEASE; RHABDOMYOMA; SEIZURE; SKIN DISEASE; SKIN MANIFESTATION; SUBEPENDYMOMA; SURGICAL TECHNIQUE; TUBEROUS SCLEROSIS; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT;

CENTRAL NERVOUS SYSTEM; EYE DISEASES; HEART NEOPLASMS; HUMANS; KIDNEY; LUNG DISEASES; MAGNETIC RESONANCE IMAGING; NERVOUS SYSTEM DISEASES; RHABDOMYOMA; SKIN; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 33745481867     PISSN: 10719091     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.spen.2006.01.008     Document Type: Article

References (80)

1. Osborne J.P., Fryer A., and Webb D. Epidemiology of tuberous sclerosis. Ann N Y Acad Sci 615 (1991) 125-127
2. Wiederholt W.C., Gomez M.R., and Kurland L.T. Incidence and prevalence of tuberous sclerosis in Rochester, Minnesota, 1950 through 1982. Neurology 35 (1985) 600-603
3. Roach E.S., Gomez M.R., and Northrup H. Tuberous sclerosis complex consensus conference. Revised clinical diagnostic criteria. J Child Neurol 13 (1998) 624-628
4. Roach E.S., DiMario F.J., Kandt R.S., et al. Tuberous sclerosis consensus conference. recommendations for diagnostic evaluation. J Child Neurol 14 (1999) 401-407
5. Dabora S.L., Jozwiak S., Franz D.N., et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 68 (2001) 64-80
6. Cheadle J.P., Reeve M.P., Sampson J.R., et al. Molecular genetic advances in tuberous sclerosis. Hum Genet 107 (2000) 97-114
7. Christophe C., Sekhara T., Rypens F., et al. MRI spectrum of cortical malformations in tuberous sclerosis complex. Brain Dev 22 (2000) 487-493
8. DiMario F.J. Brain abnormalities in tuberous sclerosis complex. J Child Neurol 19 (2004) 650-657
9. Inoue Y., Nemoto Y., Murata R., et al. CT and MR imaging of cerebral tuberous sclerosis. Brain Dev 20 (1998) 209-221
10. Braffman B.H., Bilaniuk L.T., Naidich T.P., et al. MR imaging of tuberous sclerosis. pathogenesis of this phakomatosis, use of gadopentetate dimeglumine, and literature review. Radiology 183 (1992) 227-238
11. Scheithauer B.W., and Reagan T.J. Neuropathology. In: Gomez M.R., Sampson J.R., and Whittemore V.H. (Eds). Tuberous Sclerosis Complex. (ed 3) (1999), Oxford University Press, New York, NY 101-144
12. Maeda M., Tartaro A., Matsuda T., et al. Cortical and subcortical tubers in tuberous sclerosis and FLAIR sequence. J Comput Assist Tomogr 19 (1995) 660-661
13. Baron Y., and Barkovich A.J. MR Imaging of tuberous sclerosis in neonates and young infants. AJNR Am J Neuroradiol 20 (1999) 907-916
14. Iwasaki S., Nakagawa H., Kichikawa K., et al. MR and CT of tuberous sclerosis. Linear abnormalities in the cerebral white matter. AJNR Am J Neuroradiol 11 (1990) 1029-1034
15. Hosoya M., Naito H., and Nihei K. Neurological prognosis correlated with variations over time in the number of subependymal nodules in tuberous sclerosis. Brain Dev 21 (1999) 544-547
16. Goh S., Butler W., and Thiele E.A. Subependymal giant cell tumors in tuberous sclerosis complex. Neurology 63 (2004) 1457-1461
17. Ess K.C., Kamp C.A., Tu B.P., et al. Developmental origin of subependymal giant cell astrocytomas in tuberous sclerosis complex. Neurology 64 (2005) 1446-1449
18. Gomez M.R. Natural history of cerebral tuberous sclerosis. In: Gomez M.R., Sampson J.R., and Whittemore V.H. (Eds). Tuberous Sclerosis Complex. (ed 3) (1999), Oxford University Press, New York, NY 29-46
19. Goodman M., Lamm S.H., Engel A., et al. Cortical tuber count. a biomarker indicating neurologic severity of tuberous sclerosis complex. J Child Neurol 12 (1997) 85-90
20. Curatolo P., Seri S., Verdecchia M., et al. Infantile spasms in tuberous sclerosis complex. Brain Dev 23 (2001) 502-507
21. Fukushima K., Inoue Y., Fujiwara T., et al. Long-term follow-up study of West syndrome associated with tuberous sclerosis. Brain Dev 23 (2001) 698-704
22. Lazarowski A., Lubieniecki F., Camarero S., et al. Multidrug resistance proteins in tuberous sclerosis and refractory epilepsy. Pediatr Neurol 30 (2004) 102-106
23. Curatolo P., Verdecchia M., and Bombardieri R. Vigabatrin for tuberous sclerosis complex. Brain Dev 23 (2001) 649-653
24. Mackay M.T., Weiss S.K., Adams-Weber T., et al. Practice parameter. medical treatment of infantile spasms. Neurology 62 (2004) 1668-1681
25. Hancock E., and Osborne J.P. Vigabatrin in the treatment of infantile spasms in tuberous sclerosis. literature review. J Child Neurol 14 (1999) 71-74
26. Aicardi J., Mumford J.P., Dumas C., et al. Vigabatrin as initial therapy for infantile spasms. a European retrospective study. Epilepsia 37 (1996) 638-642
27. Thiele E.A. Assessing the efficacy of antiepileptic treatments. the ketogenic diet. Epilepsia 44 Suppl 7 (2003) 26-29
28. Parain D., Penniello M.J., Berquen P., et al. Vagal nerve stimulation in tuberous sclerosis complex patients. Pediatr Neurol 25 (2001) 213-216
29. Jarrar R.G., Buchhalter J.R., and Raffel C. Long-term outcome of epilepsy surgery in patients with tuberous sclerosis. Neurology 62 (2004) 479-481
30. Karenfort M., Kruse B., Freitag H., et al. Epilepsy surgery outcome in children with focal epilepsy due to tuberous sclerosis complex. Neuropediatrics 33 (2002) 255-261
31. Lachhwani D.K., Pestana E., Gupta A., et al. Identification of candidates for epilepsy surgery in patients with tuberous sclerosis. Neurology 64 (2005) 1651-1654
32. Yapici Z., Dincer A., and Eraksoy M. Proton spectroscopic findings in children with epilepsy owing to tuberous sclerosis complex. J Child Neurol 20 (2005) 517-522
33. Koh S., Jayakar P., Resnick T., et al. The localizing value of ictal SPECT in children with tuberous sclerosis complex and refractory partial epilepsy. Epileptic Disord 1 (1999) 41-46
34. 11C. methyl-L-tryptophan positron emission tomography. Ann Neurol 44 (1998) 858-866
35. Jansen F.E., Braun K.P., van Nieuwenhuizen O., et al. Diffusion-weighted magnetic resonance imaging and identification of the epileptogenic tuber in patients with tuberous sclerosis. Arch Neurol 60 (2003) 1580-1584
36. Karadag D., Mentzel H.J., Gullmar D., et al. Diffusion tensor imaging in children and adolescents with tuberous sclerosis. Pediatr Radiol 35 (2005) 980-983
37. Romanelli P., Najjar S., Weiner H.L., et al. Epilepsy surgery in tuberous sclerosis. multistage procedures with bilateral or multilobar foci. J Child Neurol 17 (2002) 689-692
38. Joinson C., O'Callaghan F.J., Osborne J.P., et al. Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex. Psych Med 33 (2003) 335-344
39. Harrison J.E., O'Callaghan F.J., Hancock E., et al. Cognitive deficits in normally intelligent patients with tuberous sclerosis. Am J Med Genet 88 (1999) 642-646
40. O'Callaghan F.J.K., Harris T., Joinson C., et al. The relation of infantile spasms, tubers and intelligence in tuberous sclerosis complex. Arch Dis Child 89 (2004) 530-533
41. Goh S., Kwiatkowski D.J., Dorer D.J., et al. Infantile spasms and intellectual outcomes in children with tuberous sclerosis complex. Neurology 65 (2005) 235-238
42. Lewis J.C., Thomas H.V., Murphy K.C., et al. Genotype and psychological phenotype in tuberous sclerosis. J Med Genet 41 (2004) 203-207
43. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. (ed 4) (1994), American Psychiatric Association, Washington, DC
44. Dowling M., and Curatolo P. Autism. In: Curatolo P. (Ed). Tuberous Sclerosis Complex. From Basic Science to Clinical Phenotypes (2003), Mac Keith Press, London 91-108
45. Smalley S.L. Autism and tuberous sclerosis. J Autism Dev Disord 28 (1998) 407-414
46. Bolton P.F., Park R.J., Higgins J.N.P., et al. Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex. Brain 125 (2002) 1247-1255
47. Asano E., Chugani D.C., Muzik O., et al. Autism in tuberous sclerosis complex is related to both cortical and subcortical dysfunction. Neurology 57 (2001) 1269-1277
48. Bolton P.F., and Griffiths P.D. Association of tuberous sclerosis of temporal lobes with autism and atypical autism. Lancet 349 (1997) 392-395
49. Curatolo P., Cusmai R., Cortesi F., et al. Neuropsychiatric aspects of tuberous sclerosis. Ann N Y Acad Sci 615 (1991) 8-16
50. Weber A.M., Egelhoff J.C., McKellop J.M., et al. Autism and the cerebellum. evidence from tuberous sclerosis. J Autism Dev Disord 30 (2000) 511-517
51. Webb D.W., Clarke A., Fryer A., et al. The cutaneous features of tuberous sclerosis. A population study. Br J Derm 135 (1996) 1-5
52. Jozwiak S., Schwartz R.A., Janniger C.K., et al. Skin lesions in children with tuberous sclerosis complex. their prevalence, natural course, and diagnostic significance. Int J Derm 37 (1998) 911-917
53. Vanderhooft S.L., Francis J.S., Pagon R.A., et al. Prevalence of hypopigmented macules in a healthy population. J Pediatr 129 (1996) 355-361
54. Rogers R.S., and O'onnor W.J. Dermatologic manifestations. In: Gomez M.R., Sampson J.R., and Whittemore V.H. (Eds). Tuberous Sclerosis Complex. (ed 3) (1999), Oxford University Press, New York, NY 160-180
55. Ewalt D.H., Sheffield E., Sparagana S.P., et al. Renal lesion growth in children with tuberous sclerosis. J Urol 160 (1998) 141-145
56. O'Callaghan F.J., Noakes M.J., Martyns C.N., et al. An epidemiological study of renal pathology in tuberous sclerosis complex. BJU Int 94 (2004) 853-857
57. Casper K.A., Donnelly L.F., Chen B., et al. Tuberous sclerosis complex. renal imaging findings. Radiology 225 (2002) 451-456
58. Bissler J.J., and Kingswood J.C. Renal angiomyolipomata. Kidney Int 66 (2004) 924-934
59. El-Hashemite N., Zhang H., Henske E.P., et al. Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma. Lancet 361 (2003) 1348-1349
60. Henske E.P. Tuberous sclerosis and the kidney. from mesenchyme to epithelium, and beyond. Pediatr Nephrol 20 (2005) 854-857
61. Sampson J.R., Maheshwar M.M., Aspinwall R., et al. Renal cystic disease in tuberous sclerosis. Role of the polycystic kidney disease 1 gene. Am J Hum Genet 61 (1997) 843-851
62. Tello R., Blickman J.G., Buonomo C., et al. Meta analysis of the relationship between tuberous sclerosis complex and renal cell carcinoma. Eur J Radiol 27 (1998) 131-138
63. Freedom R.M., Lee K.J., MacDonald C., et al. Selected aspects of cardiac tumors in infancy and childhood. Pediatr Cardiol 21 (2000) 299-316
64. Bader R.S., Chitayat D., Kelly E., et al. Fetal rhabdomyoma. Prenatal diagnosis, clinical outcome, and incidence of associated tuberous sclerosis complex. J Pediatr 143 (2003) 620-624
65. Becker A.E. Primary heart tumors in the pediatric age group. a review of salient pathologic features relevant for clinicians. Pediatr Cardiol 21 (2000) 317-323
66. Franz D.N. Non-neurologic manifestations of tuberous sclerosis complex. J Child Neurol 19 (2004) 690-698
67. Nir A., Tajik A.J., Freeman W.K., et al. Tuberous sclerosis and cardiac rhabdomyoma. Amer J Cardiol 76 (1995) 419-421
68. Kumasaka T., Seyama K., Mitani K.M.T., et al. Lymphangiogenesis in lymphangioleiomyomatosis. Its implication in the progression of lymphangioleiomyomatosis. Am J Surg Pathol 28 (2004) 1007-1016
69. Sullivan E.J. Lymphangioleimyomatosis Chest 114 (1998) 1689-1703
70. Castro M., Sheperd C.W., Gomez M.R., et al. Pulmonary tuberous sclerosis. Chest 107 (1995) 189-195
71. Aubry M.C., Myers J.L., Ryu J.H., et al. Pulmonary lymphangioleiomyomatosis in a man. Am J Respir Crit Care Med 162 (2000) 749-752
72. Dwyer J.M., Hickie J.B., and Garvan J. Pulmonary tuberous sclerosis. Report of three patients and a review of the literature. Q J Med 40 (1971) 115-125
73. Costello L.C., Hartman T.E., and Ryu J.H. High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex. Mayo Clin Proc 75 (2000) 591-594
74. Wahedna I., Cooper S., Williams J., et al. Relation of pulmonary lymphangio-leiomyomatosis to use of the oral contraceptive pill and fertility in the UK. a national case control study. Thorax 49 (1994) 910-994
75. Franz D.N., Brody A., Meyer C., et al. Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis. Am J Respir Crit Care Med 164 (2001) 661-668
76. Strizheva G.D., Carsillo T., Kruger W.D., et al. The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis. Am J Respir Crit Care Med 163 (2001) 253-258
77. Astrinidis A., and Henske E.P. Aberrant cellular differentiation and migration in renal and pulmonary tuberous sclerosis complex. J Child Neurol 19 (2004) 710-715
78. Johnson S.R., Whale C.I., Hubbard R.B., et al. Survival and disease progression in UK patients with lymphangioleiomyomatosis. Thorax 59 (2004) 800-803
79. Rowley S.A., O'Callaghan F.J.O., and Osborne J.P. Ophthalmic manifestations of tuberous sclerosis. a population based study. Br J Ophthalmol 85 (2001) 420-423
80. Robertson D.M. Ophthalmic findings. In: Gomez M.R., Sampson J.R., and Whittemore V.H. (Eds). Tuberous Sclerosis Complex. (ed 3) (1999), Oxford University Press, New York, NY 145-159